Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$6.87 - $11.34 $79,719 - $131,589
-11,604 Reduced 88.04%
1,577 $11,000
Q1 2024

May 08, 2024

SELL
$5.11 - $8.76 $508,010 - $870,875
-99,415 Reduced 88.29%
13,181 $114,000
Q4 2023

Feb 05, 2024

BUY
$4.7 - $9.87 $528,359 - $1.11 Million
112,417 Added 62802.79%
112,596 $737,000
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $1,398 - $1,966
153 Added 588.46%
179 $1,000
Q2 2023

Aug 10, 2023

SELL
$12.09 - $15.0 $33,852 - $42,000
-2,800 Reduced 99.08%
26 $0
Q1 2023

May 09, 2023

SELL
$12.99 - $16.48 $272,257 - $345,404
-20,959 Reduced 88.12%
2,826 $39,000
Q4 2022

Feb 08, 2023

BUY
$12.5 - $24.78 $297,312 - $589,392
23,785 New
23,785 $340,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $738M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.